Skip to main content

[featured article] Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases

A task force was constituted by 24 rheumatologists (panel members), with clinical and research expertise in immunizations and infectious diseases in immunocompromised patients, endorsed by the Brazilian Society of Rheumatology (BSR), to develop guidelines for COVID-19 vaccination in patients with immune-mediated rheumatic diseases. Read more.

  1. Authors: Valderilio Feijó Azevedo, Igor Age Kos, Ana Beatriz Vargas-Santos, Geraldo da Rocha Castelar Pinheiro and Eduardo dos Santos Paiva

Guideline Collection

(see more)

Preprint sharing

We encourage archiving of primary research manuscripts on preprint servers, authors’ or institutional websites. Read more on preprint sharing and citation. 

Journal archives

Formerly named Revista Brasileira de Reumatologia, the journal is celebrating its 60th year of publication in 2020. Articles published prior to January 2018 are available here.

Celebrating Rare Diseases Month: Rare, but Frequently Seen by Rheumatologists

Guest Editor:
Dr. Sandro Félix Perazzio: Federal University of Sao Paulo, Brazil

Submission Status: Open until 1 March 2024

Aims and scope

Advances in Rheumatology is an international, open access journal publishing pre-clinical, translational and clinical studies on all aspects of paediatric and adult rheumatic diseases, including degenerative, inflammatory and autoimmune conditions. We welcome original research (including systematic reviews and meta-analyses), reviews, guidelines and letters arising from published material.
 

About the Editors-in-Chief

New Content ItemProfessor Marcos Renato de Assis, MD, PhD, Assis Medical School​​​​​​, São Paulo, Brazil

He completed his PhD in Rehabilitation at Federal University of São Paulo, in 2003, studying patients with fibromyalgia. He also has specialization in PM&R and acted as senior teaching assistant for a distance-learning training program on clinical research by Harvard Medical School (2010-2015). His interests are fibromyalgia, rheumatoid arthritis, spondyloarthritis, tools validation and distance learning.

EiC Eduardo S. PaivaProfessor Eduardo dos Santos Paiva, MD, PhD, Federal University of Paraná, Brazil

He is Professor of Rheumatology in the Universidade Federal do Parana, in Curitiba, Brazil. He received his PhD in Internal Medicine from the same University, studying patients with fibromyalgia and obesity. He was a fellow in the Division of Arthritis and Rheumatic Diseases in the Oregon Health and Sciences University. He is a Fellow of the American College of Rheumatology. His areas of interest are fibromyalgia, pain rheumatic diseases, musculoskeletal ultrasound, and multiprofessional care for patients with rheumatic and musculoskeletal diseases.

Honorary Editors

João Francisco Marques Neto, MD, PhD, University of Campinas, São Paulo, Brazil
Adil Muhib Samara, MD, PhD, University of Campinas, São Paulo, Brazil
Hilton Seda, MD, PhD, Pontifical Catholic University of Rio de Janeiro, Brazil
Natalino Hajime Yoshinari, MD. PhD, University of São Paulo, Brazil (deceased)

About the Society

The Brazilian Society of Rheumatology (SBR) was founded in 1949 and its mission is to promote excellence in rheumatology by encouraging teaching, research and care, and contributing to the formulation of public policies aimed at the health and well-being of the rheumatic patients. SBR brings together Brazilian rheumatologists, disseminating the specialty, organizing courses and congresses, and fostering scientific research.

In 2018, the Society approved and published its Code of Ethics whose principles are intended to ensure its mission, vision, and values, according to its statuses and bylaws. Read the full document here.

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    2.3 - 2-year Impact Factor
    2.9 - 5-year Impact Factor
    0.818 - SNIP (Source Normalized Impact per Paper)
    0.686 - SJR (SCImago Journal Rank)

    2023 Speed
    23 days submission to first editorial decision for all manuscripts (Median)
    188 days submission to accept (Median)

    2023 Usage 
    546,875 downloads
    134 Altmetric mentions